| Line Item | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||
| YoY growth | +127.0% | |||||||
| Cost of revenues | ||||||||
| Gross profit (loss) | ||||||||
| % of revenue | 23.4% | |||||||
| Operating expenses: | ||||||||
| Research and development | ||||||||
| Sales and marketing | ||||||||
| General and administrative | ||||||||
| Total operating expenses | ||||||||
| % of revenue | 146.4% | |||||||
| Operating loss | ||||||||
| % of revenue | -123.0% | |||||||
| Financial income, net | ||||||||
| Loss before taxes on income | ||||||||
| Taxes on income | ||||||||
| Net loss | ||||||||
| % of revenue | -123.1% | |||||||
| Basic net loss per ordinary share | ||||||||
| Diluted net loss per ordinary share |